Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3742182015 | Physostigmine only product in ocular dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3742183013 | Product containing only physostigmine in ocular dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4637591000052112 | läkemedel som endast innehåller fysostigmin, läkemedelsform för ögon | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Physostigmine only product in ocular dose form | Is a | Product containing physostigmine in ocular dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Physostigmine only product in ocular dose form | räkning av bas i aktiv ingrediens | 1 (qualifier value) | false | Inferred relationship | Some | ||
| Physostigmine only product in ocular dose form | Has active ingredient | Physostigmine (substance) | true | Inferred relationship | Some | 1 | |
| Physostigmine only product in ocular dose form | Is a | Physostigmine only product | true | Inferred relationship | Some | ||
| Physostigmine only product in ocular dose form | Has manufactured dose form | Ocular dose form (dose form) | true | Inferred relationship | Some | ||
| Physostigmine only product in ocular dose form | Plays role | Antiglaucoma therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely physostigmine sulfate 10 milligram/1 milliliter conventional release eye solution (clinical drug) | Is a | True | Physostigmine only product in ocular dose form | Inferred relationship | Some | |
| Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) | Is a | True | Physostigmine only product in ocular dose form | Inferred relationship | Some | |
| Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug) | Is a | True | Physostigmine only product in ocular dose form | Inferred relationship | Some |
Reference Sets
FHIR